The emerging roles of B cells in cancer development

Fan Xiao,Dongmei Zhou,Meng Cao,Haijing Wu,Chunxing Zheng,Ke Rui,Liwei Lu

DOI: https://doi.org/10.1038/s41423-024-01211-4

2024-08-27

Cellular and Molecular Immunology

Abstract:B cells arise from the bone marrow and differentiate into various functional subsets in the peripheral lymphoid organs and inflammatory sites. Whereas T cells have been recognized as the dominant immune population in the tumor microenvironment, increasing evidence has shown the involvement of B cells in cancer development [1]. Within tertiary lymphoid structures (TLSs), which consist of aggregates of spatially organized immune cells in tumors, B cells actively interact with other populations and promote immunotherapy responses [1, 2]. However, the cellular heterogeneity, functional diversity, and underlying mechanisms of B-cell subsets across diverse cancer types remain major challenges for dissecting the roles of B cells in tumor development and immunotherapies. In newly published papers in Science and Cell , two research groups independently established pancancer landscapes of tumor-infiltrating B cells across major human cancer types by integrating single-cell transcriptomes, B-cell-receptor (BCR) repertoires, chromatin accessibility data, and clinical prognostic information [3, 4]. Using public datasets and their generated single-cell RNA sequencing (scRNA-seq) data derived from cancer patients, Ma et al. identified 15 distinct B-cell subsets, whereas Yang et al. discovered a total of 20 fine-grained B-cell subpopulations, both of which showed significant tissue and cancer-type preferences. These two studies successfully characterized major B-cell subsets during different maturation stages, including naïve B cells, pre-germinal center and germinal center (GC)B cells, memory B cells, and plasma cells, on the basis of their hallmark gene expression signatures. Notably, they revealed the molecular phenotypes and functional features of novel B-cell subsets, including stressed B cells and tumor-associated atypical B (TAAB) cells, across cancer types. These novel findings revealed the existence of diverse functional B-cell subsets at the pancancer level and their associations with the clinical prognosis of cancer patients.

immunology